Aurobindo Pharma receives USFDA approval for Mometasone Furoate Monohydrate nasal spray
The approved product has an estimated market size of US$ 44.5 million for the twelve months ending January 2024
The approved product has an estimated market size of US$ 44.5 million for the twelve months ending January 2024
Nasonex is a registered trademark of Organon and is used by Perrigo and its affiliates under license
Subscribe To Our Newsletter & Stay Updated